Exeliom Biosciences

Dijon, France · Founded 2016 · Privately Held (backing)

Developer of immunotherapies designed to help harness the therapeutic potential of gut microbiota. Exeliom Biosciences is based in Dijon, France and was founded in 2016. Its last reported valuation was $7.4 million in Dec 2018. It has raised $33.3 million.

Last reported valuation
$7.4M
Oct 2026
Priced at
—
Total raised
$33.3M
Last round
—

Who backs Exeliom Biosciences?

19 investors
InvestorType
BpifranceOther
European Innovation CouncilVenture capital
UI InvestissementPE / buyout
Elaia PartnersVenture capital
CE-Ventures—
Capital Grand EstPE / buyout
Auriga Partners (Paris)—
Biocodex—
Cap Innov Est—
CresVentures—
+ 9 more investors · a free account shows the complete list
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

Exeliom Biosciences investors

19 investors are on record for Exeliom Biosciences, including Bpifrance, European Innovation Council, UI Investissement and Elaia Partners.

Free account
More of Exeliom Biosciences with a free account
  • ·The complete investor list: 19 names
  • ·Watch Exeliom Biosciences: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 19 firms already write checks for companies like Exeliom Biosciences. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View